M Lund, E Trolle. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Administration, OralAdolescentAdultAgedAnticonvulsants/administration & dosageAnticonvulsants/adverse effectsAnticonvulsants/therapeutic useBenzodiazepinones/administration & dosageBenzodiazepinones/adverse effectsBenzodiazepinones/therapeutic useChildChlorobenzenes/administration & dosageChlorobenzenes/adverse effectsChlorobenzenes/therapeutic useDrug EvaluationDrug Therapy, CombinationEpilepsy/drug therapyFatigue/chemically inducedFemaleHumansMaleMiddle AgedNitro Compounds/administration & dosageNitro Compounds/adverse effectsNitro Compounds/therapeutic useSuspensionsTabletsTime Factors
Substances: See more » AnticonvulsantsBenzodiazepinonesChlorobenzenesNitro CompoundsSuspensionsTablets
Year: 1973 PMID: 4519461 DOI: 10.1111/j.1600-0404.1973.tb02289.x
Source DB: PubMed Journal: Acta Neurol Scand Suppl ISSN: 0065-1427